Evidence map›Paper›PMID 28806951›Full record

ArticleBMC complementary and alternative medicine2017

Phytochemical analysis and in vitro anthelmintic activity of Lophira lanceolata (Ochnaceae) on the bovine parasite Onchocerca ochengi and on drug resistant strains of the free-living nematode Caenorhabditis elegans.

Justin Kalmobé, Dieudonné Ndjonka, Djafsia Boursou, Jacqueline Dikti Vildina, Eva Liebau

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Anthelmintic Potential of DiscardedJournal of pharmacopuncture · 2024
    Article
  2. Anthelmintic activity of crude and separated extract ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Article
  3. Heliyon · 2023
    Article
  4. Journal of tropical medicine · 2023
    Article
  5. Antihelminthic Activity ofJournal of tropical medicine · 2023
    Article
  6. New Insights Into The Evolution of Chloroplast Genomes inEvolutionary bioinformatics online · 2023
    Article
  7. Anthelmintic Agents from African Medicinal Plants: Review and Prospects.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  8. Antifilarial Activity of the Methanolic Extract ofJournal of parasitology research · 2022
    Article
  9. Article
  10. Antioxidants (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Justin KalmobéDepartment of Biological Sciences, Faculty of Science, University of Ngaoundéré, PO, Box 454, Ngaoundéré, Cameroon.
Dieudonné NdjonkaDepartment of Biological Sciences, Faculty of Science, University of Ngaoundéré, PO, Box 454, Ngaoundéré, Cameroon. ndjonka_dede@yahoo.com.
Djafsia BoursouDepartment of Biological Sciences, Faculty of Science, University of Ngaoundéré, PO, Box 454, Ngaoundéré, Cameroon.
Jacqueline Dikti VildinaDepartment of Biological Sciences, Faculty of Science, University of Ngaoundéré, PO, Box 454, Ngaoundéré, Cameroon.
Eva LiebauDepartment of Molecular Physiology, Institute for Zoophysiology, Schlossplatz 8, 48143, Muenster, Germany.
University of Ngaoundéré · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOnchocerciasis is one of the tropical neglected diseases (NTDs) caused by the nematode Onchocerca volvulus. Control strategies currently in use rely on mass administration of ivermectin, which has marked activity against microfilariae. Furthermore, the development of resistance to ivermectin was observed. Since vaccine and safe macrofilaricidal treatment against onchocerciasis are still lacking, there is an urgent need to discover novel drugs. This study was undertaken to investigate the anthelmintic activity of Lophira lanceolata on the cattle parasite Onchocerca ochengi and the anthelmintic drug resistant strains of the free living nematode Caenorhabditis elegans and to determine the phytochemical profiles of the extracts and fractions of the plants.

methodsPlant was extracted in ethanol or methanol-methylene chloride. O. ochengi, C. elegans wild-type and C. elegans drug resistant strains were cultured in RPMI-1640 and NGM-agar respectively. Drugs diluted in dimethylsulphoxide/RPMI or M9-Buffer were added in assays and monitored at 48 h and 72 h. Worm viability was determined by using the MTT/formazan colorimetric method. Polyphenol, tannin and flavonoid contents were determined by dosage of gallic acid and rutin. Acute oral toxicity was evaluated using Swiss albino mice.

resultsEthanolic and methanolic-methylene chloride extracts killed O. ochengi with LC

conclusionEthanolic and methanolic-methylene chloride crude extracts and fractions of L. lanceolata showed in vitro anthelmintic activity. The extracts and fractions contained polyphenols, tannins, flavonoids and saponins. The mechanism of action of this plant could be different from that of albendazole and ivermectin. These results confirm the use of L. lanceolata by traditional healers for the treatment of worm infections.

Indexed as

Caenorhabditis elegansOnchocercaAlbendazoleAnimalsAnthelminticsCattleDrug ResistanceFlavonoidsIvermectinMiceNematode InfectionsOchnaceaeOnchocerciasisPhytotherapyPlant BarkPlant ExtractsAlbendazoleAnthelminticsFlavonoidsIvermectinPlant ExtractsPolyphenolsSaponinsTanninsAcute toxicityAnthelminticDrug resistant strainsLophira lanceolataOnchocerca ochengiTraditional healers

Identifiers

PMID28806951
PMCPMC5557511
OpenAlexW2746703558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.